Table of Content

1 Market Overview of Immuno-Cell Therapy
1.1 Immuno-Cell Therapy Market Overview
1.1.1 Immuno-Cell Therapy Product Scope
1.1.2 Immuno-Cell Therapy Market Status and Outlook
1.2 Global Immuno-Cell Therapy Market Size Overview by Region 2018 VS 2022 VS 2033
1.3 Global Immuno-Cell Therapy Market Size by Region (2018-2033)
1.4 Global Immuno-Cell Therapy Historic Market Size by Region (2018-2023)
1.5 Global Immuno-Cell Therapy Market Size Forecast by Region (2024-2033)
1.6 Key Regions, Immuno-Cell Therapy Market Size (2018-2033)
1.6.1 North America Immuno-Cell Therapy Market Size (2018-2033)
1.6.2 Europe Immuno-Cell Therapy Market Size (2018-2033)
1.6.3 Asia-Pacific Immuno-Cell Therapy Market Size (2018-2033)
1.6.4 Latin America Immuno-Cell Therapy Market Size (2018-2033)
1.6.5 Middle East & Africa Immuno-Cell Therapy Market Size (2018-2033)
2 Immuno-Cell Therapy Market by Type
2.1 Introduction
2.1.1 Passive Immune (NK, LAK etc)
2.1.2 Active Immune
2.2 Global Immuno-Cell Therapy Market Size by Type: 2018 VS 2022 VS 2033
2.2.1 Global Immuno-Cell Therapy Historic Market Size by Type (2018-2023)
2.2.2 Global Immuno-Cell Therapy Forecasted Market Size by Type (2024-2033)
2.3 Key Regions Market Size by Type
2.3.1 North America Immuno-Cell Therapy Revenue Breakdown by Type (2018-2033)
2.3.2 Europe Immuno-Cell Therapy Revenue Breakdown by Type (2018-2033)
2.3.3 Asia-Pacific Immuno-Cell Therapy Revenue Breakdown by Type (2018-2033)
2.3.4 Latin America Immuno-Cell Therapy Revenue Breakdown by Type (2018-2033)
2.3.5 Middle East and Africa Immuno-Cell Therapy Revenue Breakdown by Type (2018-2033)
3 Immuno-Cell Therapy Market Overview by Application
3.1 Introduction
3.1.1 Oncology
3.1.2 Cardiovascular Disease (CVD)
3.1.3 Orthopedic
3.1.4 Wound Healing
3.1.5 Others
3.2 Global Immuno-Cell Therapy Market Size by Application: 2018 VS 2022 VS 2033
3.2.1 Global Immuno-Cell Therapy Historic Market Size by Application (2018-2023)
3.2.2 Global Immuno-Cell Therapy Forecasted Market Size by Application (2024-2033)
3.3 Key Regions Market Size by Application
3.3.1 North America Immuno-Cell Therapy Revenue Breakdown by Application (2018-2033)
3.3.2 Europe Immuno-Cell Therapy Revenue Breakdown by Application (2018-2033)
3.3.3 Asia-Pacific Immuno-Cell Therapy Revenue Breakdown by Application (2018-2033)
3.3.4 Latin America Immuno-Cell Therapy Revenue Breakdown by Application (2018-2033)
3.3.5 Middle East and Africa Immuno-Cell Therapy Revenue Breakdown by Application (2018-2033)
4 Immuno-Cell Therapy Competition Analysis by Players
4.1 Global Immuno-Cell Therapy Market Size by Players (2018-2023)
4.2 Global Top Players by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in Immuno-Cell Therapy as of 2022)
4.3 Date of Key Players Enter into Immuno-Cell Therapy Market
4.4 Global Top Players Immuno-Cell Therapy Headquarters and Area Served
4.5 Key Players Immuno-Cell Therapy Product Solution and Service
4.6 Competitive Status
4.6.1 Immuno-Cell Therapy Market Concentration Rate
4.6.2 Mergers & Acquisitions, Expansion Plans
5 Company (Top Players) Profiles
5.1 MEDINET Co
5.1.1 MEDINET Co Profile
5.1.2 MEDINET Co Main Business
5.1.3 MEDINET Co Immuno-Cell Therapy Products, Services and Solutions
5.1.4 MEDINET Co Immuno-Cell Therapy Revenue (US$ Million) & (2018-2023)
5.1.5 MEDINET Co Recent Developments
5.2 Erytech
5.2.1 Erytech Profile
5.2.2 Erytech Main Business
5.2.3 Erytech Immuno-Cell Therapy Products, Services and Solutions
5.2.4 Erytech Immuno-Cell Therapy Revenue (US$ Million) & (2018-2023)
5.2.5 Erytech Recent Developments
5.3 Seta Clinic Group
5.3.1 Seta Clinic Group Profile
5.3.2 Seta Clinic Group Main Business
5.3.3 Seta Clinic Group Immuno-Cell Therapy Products, Services and Solutions
5.3.4 Seta Clinic Group Immuno-Cell Therapy Revenue (US$ Million) & (2018-2023)
5.3.5 Takeda Recent Developments
5.4 Takeda
5.4.1 Takeda Profile
5.4.2 Takeda Main Business
5.4.3 Takeda Immuno-Cell Therapy Products, Services and Solutions
5.4.4 Takeda Immuno-Cell Therapy Revenue (US$ Million) & (2018-2023)
5.4.5 Takeda Recent Developments
5.5 SBI Holdings
5.5.1 SBI Holdings Profile
5.5.2 SBI Holdings Main Business
5.5.3 SBI Holdings Immuno-Cell Therapy Products, Services and Solutions
5.5.4 SBI Holdings Immuno-Cell Therapy Revenue (US$ Million) & (2018-2023)
5.5.5 SBI Holdings Recent Developments
5.6 Oxford BioTherapeutics
5.6.1 Oxford BioTherapeutics Profile
5.6.2 Oxford BioTherapeutics Main Business
5.6.3 Oxford BioTherapeutics Immuno-Cell Therapy Products, Services and Solutions
5.6.4 Oxford BioTherapeutics Immuno-Cell Therapy Revenue (US$ Million) & (2018-2023)
5.6.5 Oxford BioTherapeutics Recent Developments
5.7 Fate Therapeutics
5.7.1 Fate Therapeutics Profile
5.7.2 Fate Therapeutics Main Business
5.7.3 Fate Therapeutics Immuno-Cell Therapy Products, Services and Solutions
5.7.4 Fate Therapeutics Immuno-Cell Therapy Revenue (US$ Million) & (2018-2023)
5.7.5 Fate Therapeutics Recent Developments
5.8 Gilead Sciences
5.8.1 Gilead Sciences Profile
5.8.2 Gilead Sciences Main Business
5.8.3 Gilead Sciences Immuno-Cell Therapy Products, Services and Solutions
5.8.4 Gilead Sciences Immuno-Cell Therapy Revenue (US$ Million) & (2018-2023)
5.8.5 Gilead Sciences Recent Developments
5.9 Novartis
5.9.1 Novartis Profile
5.9.2 Novartis Main Business
5.9.3 Novartis Immuno-Cell Therapy Products, Services and Solutions
5.9.4 Novartis Immuno-Cell Therapy Revenue (US$ Million) & (2018-2023)
5.9.5 Novartis Recent Developments
5.10 Osiris
5.10.1 Osiris Profile
5.10.2 Osiris Main Business
5.10.3 Osiris Immuno-Cell Therapy Products, Services and Solutions
5.10.4 Osiris Immuno-Cell Therapy Revenue (US$ Million) & (2018-2023)
5.10.5 Osiris Recent Developments
5.11 Vericel Corporation
5.11.1 Vericel Corporation Profile
5.11.2 Vericel Corporation Main Business
5.11.3 Vericel Corporation Immuno-Cell Therapy Products, Services and Solutions
5.11.4 Vericel Corporation Immuno-Cell Therapy Revenue (US$ Million) & (2018-2023)
5.11.5 Vericel Corporation Recent Developments
5.12 Fujifilm Cellular Dynamics
5.12.1 Fujifilm Cellular Dynamics Profile
5.12.2 Fujifilm Cellular Dynamics Main Business
5.12.3 Fujifilm Cellular Dynamics Immuno-Cell Therapy Products, Services and Solutions
5.12.4 Fujifilm Cellular Dynamics Immuno-Cell Therapy Revenue (US$ Million) & (2018-2023)
5.12.5 Fujifilm Cellular Dynamics Recent Developments
5.13 JCR Pharmaceuticals
5.13.1 JCR Pharmaceuticals Profile
5.13.2 JCR Pharmaceuticals Main Business
5.13.3 JCR Pharmaceuticals Immuno-Cell Therapy Products, Services and Solutions
5.13.4 JCR Pharmaceuticals Immuno-Cell Therapy Revenue (US$ Million) & (2018-2023)
5.13.5 JCR Pharmaceuticals Recent Developments
5.14 Beike Biotechnology
5.14.1 Beike Biotechnology Profile
5.14.2 Beike Biotechnology Main Business
5.14.3 Beike Biotechnology Immuno-Cell Therapy Products, Services and Solutions
5.14.4 Beike Biotechnology Immuno-Cell Therapy Revenue (US$ Million) & (2018-2023)
5.14.5 Beike Biotechnology Recent Developments
5.15 Golden Meditech
5.15.1 Golden Meditech Profile
5.15.2 Golden Meditech Main Business
5.15.3 Golden Meditech Immuno-Cell Therapy Products, Services and Solutions
5.15.4 Golden Meditech Immuno-Cell Therapy Revenue (US$ Million) & (2018-2023)
5.15.5 Golden Meditech Recent Developments
5.16 Guanhao Biotech
5.16.1 Guanhao Biotech Profile
5.16.2 Guanhao Biotech Main Business
5.16.3 Guanhao Biotech Immuno-Cell Therapy Products, Services and Solutions
5.16.4 Guanhao Biotech Immuno-Cell Therapy Revenue (US$ Million) & (2018-2023)
5.16.5 Guanhao Biotech Recent Developments
5.17 Beroni Group
5.17.1 Beroni Group Profile
5.17.2 Beroni Group Main Business
5.17.3 Beroni Group Immuno-Cell Therapy Products, Services and Solutions
5.17.4 Beroni Group Immuno-Cell Therapy Revenue (US$ Million) & (2018-2023)
5.17.5 Beroni Group Recent Developments
6 North America
6.1 North America Immuno-Cell Therapy Market Size by Country (2018-2033)
6.2 United States
6.3 Canada
7 Europe
7.1 Europe Immuno-Cell Therapy Market Size by Country (2018-2033)
7.2 Germany
7.3 France
7.4 U.K.
7.5 Italy
7.6 Russia
7.7 Nordic Countries
7.8 Rest of Europe
8 Asia-Pacific
8.1 Asia-Pacific Immuno-Cell Therapy Market Size by Region (2018-2033)
8.2 China
8.3 Japan
8.4 South Korea
8.5 Southeast Asia
8.6 India
8.7 Australia
8.8 Rest of Asia-Pacific
9 Latin America
9.1 Latin America Immuno-Cell Therapy Market Size by Country (2018-2033)
9.2 Mexico
9.3 Brazil
9.4 Rest of Latin America
10 Middle East & Africa
10.1 Middle East & Africa Immuno-Cell Therapy Market Size by Country (2018-2033)
10.2 Turkey
10.3 Saudi Arabia
10.4 UAE
10.5 Rest of Middle East & Africa
11 Immuno-Cell Therapy Market Dynamics
11.1 Immuno-Cell Therapy Industry Trends
11.2 Immuno-Cell Therapy Market Drivers
11.3 Immuno-Cell Therapy Market Challenges
11.4 Immuno-Cell Therapy Market Restraints
12 Research Finding /Conclusion
13 Methodology and Data Source
13.1 Methodology/Research Approach
13.1.1 Research Programs/Design
13.1.2 Market Size Estimation
13.1.3 Market Breakdown and Data Triangulation
13.2 Data Source
13.2.1 Secondary Sources
13.2.2 Primary Sources
13.3 Disclaimer
13.4 Author List

List of Figure

List of Tables
Table 1. Global Market Immuno-Cell Therapy Market Size (US$ Million) Comparison by Region 2018 VS 2022 VS 2033
Table 2. Global Immuno-Cell Therapy Market Size by Region (2018-2023) & (US$ Million)
Table 3. Global Immuno-Cell Therapy Market Size Share by Region (2018-2023)
Table 4. Global Immuno-Cell Therapy Forecasted Market Size by Region (2024-2033) & (US$ Million)
Table 5. Global Immuno-Cell Therapy Forecasted Market Size Share by Region (2024-2033)
Table 6. Global Immuno-Cell Therapy Market Size (US$ Million) by Type: 2018 VS 2022 VS 2033
Table 7. Global Immuno-Cell Therapy Market Size by Type (2018-2023) & (US$ Million)
Table 8. Global Immuno-Cell Therapy Revenue Market Share by Type (2018-2023)
Table 9. Global Immuno-Cell Therapy Forecasted Market Size by Type (2024-2033) & (US$ Million)
Table 10. Global Immuno-Cell Therapy Revenue Market Share by Type (2024-2033)
Table 11. North America Immuno-Cell Therapy Revenue by Type (2018-2023) & (US$ Million)
Table 12. North America Immuno-Cell Therapy Revenue by Type (2024-2033) & (US$ Million)
Table 13. Europe Immuno-Cell Therapy Revenue by Type (2018-2023) & (US$ Million)
Table 14. Europe Immuno-Cell Therapy Revenue by Type (2024-2033) & (US$ Million)
Table 15. Asia-Pacific Immuno-Cell Therapy Revenue by Type (2018-2023) & (US$ Million)
Table 16. Asia-Pacific Immuno-Cell Therapy Revenue by Type (2024-2033) & (US$ Million)
Table 17. Latin America Immuno-Cell Therapy Revenue by Type (2018-2023) & (US$ Million)
Table 18. Latin America Immuno-Cell Therapy Revenue by Type (2024-2033) & (US$ Million)
Table 19. Middle East and Africa Immuno-Cell Therapy Revenue by Type (2018-2023) & (US$ Million)
Table 20. Middle East and Africa Immuno-Cell Therapy Revenue by Type (2024-2033) & (US$ Million)
Table 21. Global Immuno-Cell Therapy Market Size (US$ Million) by Application: 2018 VS 2022 VS 2033
Table 22. Global Immuno-Cell Therapy Market Size by Application (2018-2023) & (US$ Million)
Table 23. Global Immuno-Cell Therapy Revenue Market Share by Application (2018-2023)
Table 24. Global Immuno-Cell Therapy Forecasted Market Size by Application (2024-2033) & (US$ Million)
Table 25. Global Immuno-Cell Therapy Revenue Market Share by Application (2024-2033)
Table 26. North America Immuno-Cell Therapy Revenue by Application (2018-2023) & (US$ Million)
Table 27. North America Immuno-Cell Therapy Revenue by Application (2024-2033) & (US$ Million)
Table 28. Europe Immuno-Cell Therapy Revenue by Application (2018-2023) & (US$ Million)
Table 29. Europe Immuno-Cell Therapy Revenue by Application (2024-2033) & (US$ Million)
Table 30. Asia-Pacific Immuno-Cell Therapy Revenue by Application (2018-2023) & (US$ Million)
Table 31. Asia-Pacific Immuno-Cell Therapy Revenue by Application (2024-2033) & (US$ Million)
Table 32. Latin America Immuno-Cell Therapy Revenue by Application (2018-2023) & (US$ Million)
Table 33. Latin America Immuno-Cell Therapy Revenue by Application (2024-2033) & (US$ Million)
Table 34. Middle East and Africa Immuno-Cell Therapy Revenue by Application (2018-2023) & (US$ Million)
Table 35. Middle East and Africa Immuno-Cell Therapy Revenue by Application (2024-2033) & (US$ Million)
Table 36. Global Immuno-Cell Therapy Revenue (US$ Million) by Players (2018-2023)
Table 37. Global Immuno-Cell Therapy Revenue Market Share by Players (2018-2023)
Table 38. Global Top Players Market Share by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in Immuno-Cell Therapy as of 2022)
Table 39. Date of Key Players Enter into Immuno-Cell Therapy Market
Table 40. Global Immuno-Cell Therapy Key Players Headquarters and Area Served
Table 41. Immuno-Cell Therapy Product Solution and Service
Table 42. Global Immuno-Cell Therapy Players Market Concentration Ratio (CR5 and HHI)
Table 43. Mergers & Acquisitions, Expansion Plans
Table 44. MEDINET Co Basic Information List
Table 45. MEDINET Co Description and Business Overview
Table 46. MEDINET Co Immuno-Cell Therapy Products, Services and Solutions
Table 47. Revenue (US$ Million) in Immuno-Cell Therapy Business of MEDINET Co (2018-2023)
Table 48. MEDINET Co Recent Developments
Table 49. Erytech Basic Information List
Table 50. Erytech Description and Business Overview
Table 51. Erytech Immuno-Cell Therapy Products, Services and Solutions
Table 52. Revenue (US$ Million) in Immuno-Cell Therapy Business of Erytech (2018-2023)
Table 53. Erytech Recent Developments
Table 54. Seta Clinic Group Basic Information List
Table 55. Seta Clinic Group Description and Business Overview
Table 56. Seta Clinic Group Immuno-Cell Therapy Products, Services and Solutions
Table 57. Revenue (US$ Million) in Immuno-Cell Therapy Business of Seta Clinic Group (2018-2023)
Table 58. Seta Clinic Group Recent Developments
Table 59. Takeda Basic Information List
Table 60. Takeda Description and Business Overview
Table 61. Takeda Immuno-Cell Therapy Products, Services and Solutions
Table 62. Revenue (US$ Million) in Immuno-Cell Therapy Business of Takeda (2018-2023)
Table 63. Takeda Recent Developments
Table 64. SBI Holdings Basic Information List
Table 65. SBI Holdings Description and Business Overview
Table 66. SBI Holdings Immuno-Cell Therapy Products, Services and Solutions
Table 67. Revenue (US$ Million) in Immuno-Cell Therapy Business of SBI Holdings (2018-2023)
Table 68. SBI Holdings Recent Developments
Table 69. Oxford BioTherapeutics Basic Information List
Table 70. Oxford BioTherapeutics Description and Business Overview
Table 71. Oxford BioTherapeutics Immuno-Cell Therapy Products, Services and Solutions
Table 72. Revenue (US$ Million) in Immuno-Cell Therapy Business of Oxford BioTherapeutics (2018-2023)
Table 73. Oxford BioTherapeutics Recent Developments
Table 74. Fate Therapeutics Basic Information List
Table 75. Fate Therapeutics Description and Business Overview
Table 76. Fate Therapeutics Immuno-Cell Therapy Products, Services and Solutions
Table 77. Revenue (US$ Million) in Immuno-Cell Therapy Business of Fate Therapeutics (2018-2023)
Table 78. Fate Therapeutics Recent Developments
Table 79. Gilead Sciences Basic Information List
Table 80. Gilead Sciences Description and Business Overview
Table 81. Gilead Sciences Immuno-Cell Therapy Products, Services and Solutions
Table 82. Revenue (US$ Million) in Immuno-Cell Therapy Business of Gilead Sciences (2018-2023)
Table 83. Gilead Sciences Recent Developments
Table 84. Novartis Basic Information List
Table 85. Novartis Description and Business Overview
Table 86. Novartis Immuno-Cell Therapy Products, Services and Solutions
Table 87. Revenue (US$ Million) in Immuno-Cell Therapy Business of Novartis (2018-2023)
Table 88. Novartis Recent Developments
Table 89. Osiris Basic Information List
Table 90. Osiris Description and Business Overview
Table 91. Osiris Immuno-Cell Therapy Products, Services and Solutions
Table 92. Revenue (US$ Million) in Immuno-Cell Therapy Business of Osiris (2018-2023)
Table 93. Osiris Recent Developments
Table 94. Vericel Corporation Basic Information List
Table 95. Vericel Corporation Description and Business Overview
Table 96. Vericel Corporation Immuno-Cell Therapy Products, Services and Solutions
Table 97. Revenue (US$ Million) in Immuno-Cell Therapy Business of Vericel Corporation (2018-2023)
Table 98. Vericel Corporation Recent Developments
Table 99. Fujifilm Cellular Dynamics Basic Information List
Table 100. Fujifilm Cellular Dynamics Description and Business Overview
Table 101. Fujifilm Cellular Dynamics Immuno-Cell Therapy Products, Services and Solutions
Table 102. Revenue (US$ Million) in Immuno-Cell Therapy Business of Fujifilm Cellular Dynamics (2018-2023)
Table 103. Fujifilm Cellular Dynamics Recent Developments
Table 104. JCR Pharmaceuticals Basic Information List
Table 105. JCR Pharmaceuticals Description and Business Overview
Table 106. JCR Pharmaceuticals Immuno-Cell Therapy Products, Services and Solutions
Table 107. Revenue (US$ Million) in Immuno-Cell Therapy Business of JCR Pharmaceuticals (2018-2023)
Table 108. JCR Pharmaceuticals Recent Developments
Table 109. Beike Biotechnology Basic Information List
Table 110. Beike Biotechnology Description and Business Overview
Table 111. Beike Biotechnology Immuno-Cell Therapy Products, Services and Solutions
Table 112. Revenue (US$ Million) in Immuno-Cell Therapy Business of Beike Biotechnology (2018-2023)
Table 113. Beike Biotechnology Recent Developments
Table 114. Golden Meditech Basic Information List
Table 115. Golden Meditech Description and Business Overview
Table 116. Golden Meditech Immuno-Cell Therapy Products, Services and Solutions
Table 117. Revenue (US$ Million) in Immuno-Cell Therapy Business of Golden Meditech (2018-2023)
Table 118. Golden Meditech Recent Developments
Table 119. Guanhao Biotech Basic Information List
Table 120. Guanhao Biotech Description and Business Overview
Table 121. Guanhao Biotech Immuno-Cell Therapy Products, Services and Solutions
Table 122. Revenue (US$ Million) in Immuno-Cell Therapy Business of Guanhao Biotech (2018-2023)
Table 123. Guanhao Biotech Recent Developments
Table 124. Beroni Group Basic Information List
Table 125. Beroni Group Description and Business Overview
Table 126. Beroni Group Immuno-Cell Therapy Products, Services and Solutions
Table 127. Revenue (US$ Million) in Immuno-Cell Therapy Business of Beroni Group (2018-2023)
Table 128. Beroni Group Recent Developments
Table 129. North America Immuno-Cell Therapy Market Size by Country (2018-2023) & (US$ Million)
Table 130. North America Immuno-Cell Therapy Market Size by Country (2024-2033) & (US$ Million)
Table 131. Europe Immuno-Cell Therapy Market Size by Country (2018-2023) & (US$ Million)
Table 132. Europe Immuno-Cell Therapy Market Size by Country (2024-2033) & (US$ Million)
Table 133. Asia-Pacific Immuno-Cell Therapy Market Size Growth Rate (CAGR) by Region (US$ Million): 2018 VS 2022 VS 2033
Table 134. Asia-Pacific Immuno-Cell Therapy Market Size by Region (2018-2023) & (US$ Million)
Table 135. Asia-Pacific Immuno-Cell Therapy Market Size by Region (2024-2033) & (US$ Million)
Table 136. Asia-Pacific Immuno-Cell Therapy Market Share by Region (2018-2023)
Table 137. Asia-Pacific Immuno-Cell Therapy Market Share by Region (2024-2033)
Table 138. Latin America Immuno-Cell Therapy Market Size Growth Rate (CAGR) by Region (US$ Million): 2018 VS 2022 VS 2033
Table 139. Latin America Immuno-Cell Therapy Market Size by Country (2018-2023) & (US$ Million)
Table 140. Latin America Immuno-Cell Therapy Market Size by Country (2024-2033) & (US$ Million)
Table 141. Middle East & Africa Immuno-Cell Therapy Market Size Growth Rate (CAGR) by Region (US$ Million): 2018 VS 2022 VS 2033
Table 142. Middle East & Africa Immuno-Cell Therapy Market Size by Country (2018-2023) & (US$ Million)
Table 143. Middle East & Africa Immuno-Cell Therapy Market Size by Country (2024-2033) & (US$ Million)
Table 144. Immuno-Cell Therapy Market Trends
Table 145. Immuno-Cell Therapy Market Drivers
Table 146. Immuno-Cell Therapy Market Challenges
Table 147. Immuno-Cell Therapy Market Restraints
Table 148. Research Programs/Design for This Report
Table 149. Key Data Information from Secondary Sources
Table 150. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Immuno-Cell Therapy Market Size Year-over-Year 2018-2033 & (US$ Million)
Figure 2. Global Immuno-Cell Therapy Market Size (US$ Million), 2018 VS 2022 VS 2033
Figure 3. Global Immuno-Cell Therapy Market Share by Regions: 2022 VS 2033
Figure 4. Global Immuno-Cell Therapy Forecasted Market Size Share by Region (2024-2033)
Figure 5. North America Immuno-Cell Therapy Market Size Growth Rate (2018-2033) & (US$ Million)
Figure 6. Europe Immuno-Cell Therapy Market Size Growth Rate (2018-2033) & (US$ Million)
Figure 7. Asia-Pacific Immuno-Cell Therapy Market Size Growth Rate (2018-2033) & (US$ Million)
Figure 8. Latin America Immuno-Cell Therapy Market Size Growth Rate (2018-2033) & (US$ Million)
Figure 9. Middle East & Africa Immuno-Cell Therapy Market Size Growth Rate (2018-2033) & (US$ Million)
Figure 10. Product Picture of Passive Immune (NK, LAK etc)
Figure 11. Global Passive Immune (NK, LAK etc) Market Size (US$ Million) & YoY Growth (2018-2033)
Figure 12. Product Picture of Active Immune
Figure 13. Global Active Immune Market Size (US$ Million) & YoY Growth (2018-2033)
Figure 14. Global Immuno-Cell Therapy Market Size Share by Type: 2022 & 2033
Figure 15. North America Immuno-Cell Therapy Revenue Market Share by Type (2018-2033)
Figure 16. Europe Immuno-Cell Therapy Revenue Market Share by Type (2018-2033)
Figure 17. Asia-Pacific Immuno-Cell Therapy Revenue Market Share by Type (2018-2033)
Figure 18. Latin America Immuno-Cell Therapy Revenue Market Share by Type (2018-2033)
Figure 19. Middle East and Africa Immuno-Cell Therapy Revenue Market Share by Type (2018-2033)
Figure 20. Oncology Market Size (US$ Million) & YoY Growth (2018-2033)
Figure 21. Cardiovascular Disease (CVD) Market Size (US$ Million) & YoY Growth (2018-2033)
Figure 22. Orthopedic Market Size (US$ Million) & YoY Growth (2018-2033)
Figure 23. Wound Healing Market Size (US$ Million) & YoY Growth (2018-2033)
Figure 24. Others Market Size (US$ Million) & YoY Growth (2018-2033)
Figure 25. Global Immuno-Cell Therapy Market Size Share by Application: 2022 & 2033
Figure 26. North America Immuno-Cell Therapy Revenue Market Share by Application (2018-2033)
Figure 27. Europe Immuno-Cell Therapy Revenue Market Share by Application (2018-2033)
Figure 28. Asia-Pacific Immuno-Cell Therapy Revenue Market Share by Application (2018-2033)
Figure 29. Latin America Immuno-Cell Therapy Revenue Market Share by Application (2018-2033)
Figure 30. Middle East and Africa Immuno-Cell Therapy Revenue Market Share by Application (2018-2033)
Figure 31. Immuno-Cell Therapy Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2018 VS 2022
Figure 32. Global Top 5 and Top 10 Players Immuno-Cell Therapy Market Share in 2022
Figure 33. North America Immuno-Cell Therapy Market Share by Country (2018-2033)
Figure 34. United States Immuno-Cell Therapy Market Size (2018-2033) & (US$ Million)
Figure 35. Canada Immuno-Cell Therapy Market Size (2018-2033) & (US$ Million)
Figure 36. Germany Immuno-Cell Therapy Market Size (2018-2033) & (US$ Million)
Figure 37. France Immuno-Cell Therapy Market Size (2018-2033) & (US$ Million)
Figure 38. U.K. Immuno-Cell Therapy Market Size (2018-2033) & (US$ Million)
Figure 39. Italy Immuno-Cell Therapy Market Size (2018-2033) & (US$ Million)
Figure 40. Russia Immuno-Cell Therapy Market Size (2018-2033) & (US$ Million)
Figure 41. Nordic Countries Immuno-Cell Therapy Market Size (2018-2033) & (US$ Million)
Figure 42. Asia-Pacific Immuno-Cell Therapy Market Share by Region (2018-2033)
Figure 43. China Immuno-Cell Therapy Market Size (2018-2033) & (US$ Million)
Figure 44. Japan Immuno-Cell Therapy Market Size (2018-2033) & (US$ Million)
Figure 45. South Korea Immuno-Cell Therapy Market Size (2018-2033) & (US$ Million)
Figure 46. Southeast Asia Immuno-Cell Therapy Market Size (2018-2033) & (US$ Million)
Figure 47. India Immuno-Cell Therapy Market Size (2018-2033) & (US$ Million)
Figure 48. Australia Immuno-Cell Therapy Market Size (2018-2033) & (US$ Million)
Figure 49. Latin America Immuno-Cell Therapy Market Share by Country (2018-2033)
Figure 50. Mexico Immuno-Cell Therapy Market Size (2018-2033) & (US$ Million)
Figure 51. Brazil Immuno-Cell Therapy Market Size (2018-2033) & (US$ Million)
Figure 52. Middle East & Africa Immuno-Cell Therapy Market Share by Country (2018-2033)
Figure 53. Turkey Immuno-Cell Therapy Market Size (2018-2033) & (US$ Million)
Figure 54. Saudi Arabia Immuno-Cell Therapy Market Size (2018-2033) & (US$ Million)
Figure 55. UAE Immuno-Cell Therapy Market Size (2018-2033) & (US$ Million)
Figure 56. Bottom-up and Top-down Approaches for This Report